MH
Insider
Michael Thomas Henderson
DirectorMichael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.0M
shares × price, as filed
Last traded
Jul 8
Filed Jul 10
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $41.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$2.7M20,000 sh × $133.63
Exec Jul 8
Filed Jul 10 · 8:00 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $2.0M
20,000 sh × $100.00
Exec Jun 22
Filed Jun 23 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $10.6M
80,000 sh × $132.54
Exec Jun 22
Filed Jun 24 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.5M
18,306 sh across 4 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.6M
20,000 sh across 2 lots
Exec May 13
Filed May 15 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $6.0M
80,000 sh across 4 lots
Exec May 8
Filed May 8 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.6M
19,800 sh across 2 lots
Exec Apr 8
Filed Apr 10 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.5M
20,000 sh across 3 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET More filings →